H.R. 4374 · 115th Congress
To amend the Federal Food, Drug, and Cosmetic Act to authorize additional emergency uses for medical products to reduce deaths and severity of injuries caused by agents of war, and for other purposes.
- Stage
- Signed by the president
- Sponsor
- Greg Walden
- Introduced
- 2017-11-13
- Latest action
- 2017-12-12 · Signed by President.
Action history
- 2017-12-12Signed by President.
- 2017-11-30Presented to President.
- 2017-11-16Passed Senate without amendment by Unanimous Consent.
- 2017-11-16Message on Senate action sent to the House.
- 2017-11-15Motion to reconsider laid on the table Agreed to without objection.
- 2017-11-15On motion to suspend the rules and pass the bill Agreed to by voice vote.
- 2017-11-15DEBATE - The House proceeded with forty minutes of debate on H.R. 4374.
- 2017-11-15Considered under suspension of the rules.
- 2017-11-15Mr. Walden moved to suspend the rules and pass the bill.
- 2017-11-15Received in the Senate, read twice.
- 2017-11-14Referred to the Subcommittee on Military Personnel.
- 2017-11-13Introduced in House
- 2017-11-13Referred to the Committee on Energy and Commerce, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2017-11-13Referred to the Committee on Energy and Commerce, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.